China's Inbound Medical Tourism Hits 1.28 Million Patients in 2025 — And the Growth Is Just Getting Started

🔍 The Numbers Behind the Headlines

When analysts talk about China's medical tourism potential, they usually talk about it as a future story. But the numbers from 2025 suggest the future may have already arrived — at least in pockets.

China reported 1.28 million foreign patients across its hospitals in 2025, according to data cited by Daxue Consulting and corroborated by national health statistics. The headline figure, however, doesn't capture the full picture. The most dramatic growth is concentrated in specific zones and service categories.

The Boao Lecheng International Medical Tourism Pilot Zone in Hainan Province stands out. With its "zero-tariff" import policy for approved medical devices and drugs, Lecheng attracted 865,300 medical tourism visits in 2025 — a 109.18% jump from the previous year. That's more than doubling in size in a single year.

🏥 What's Drawing International Patients to China?

The CGTN report from early April 2026 highlighted several concrete drivers behind China's growing inbound medical appeal:

• Cost advantages — Major procedures and screenings often cost 60-90% less than in the US or Western Europe, even at top-tier hospitals
• Advanced technology access — Early access to treatments and devices through Lecheng's special approval pathway
• Visa policy relaxation — Shanghai's 240-hour visa-free transit policy now makes it practical to combine leisure or business travel with a medical appointment
• JCI-accredited hospitals — A growing number of Chinese hospitals have earned Joint Commission International accreditation, addressing quality concerns
• Preventive health screenings — Comprehensive executive health checks at a fraction of Western prices

🌏 How China Compares to Established Medical Tourism Destinations

China isn't competing directly with Thailand or Singapore yet — those countries have decades of infrastructure, word-of-mouth networks, and established medical tourism ecosystems. But the comparison table below shows where China is already matching or exceeding expectations:

⚠️ Where China Still Has Ground to Cover

Despite the momentum, observers — including MedicalTourismWatch.com — note that China has not yet built the comprehensive "medical + tourism" service infrastructure that Thailand and Malaysia have refined over years. The gaps that remain:

• Coordinated patient journey — Thailand has travel agencies, hotels, and hospitals working as an integrated ecosystem. China is still building those connections.
• Insurance portability — Few international health insurers cover treatment in China, creating out-of-pocket barriers.
• Post-treatment follow-up — Continuity of care across borders remains a challenge for international patients.
• Brand recognition — Most international patients still can't name a Chinese hospital. Thailand's Bumrungrad is a household name in medical tourism circles; China's equivalents are less known.

🏗️ Government Push: Nine Ministries, One Ambition

China's policy direction is unambiguous. Nine government ministries, including the Ministry of Commerce, have jointly launched measures to position medical services as a key pillar of inbound consumption. The goal is explicit: turn China from a medical tourism source market into a destination.

The Economist noted in a February 2026 feature that foreigners are increasingly seeking healthcare in China — not just because of cost, but because certain treatments and diagnostic capabilities in China now match or exceed what patients would find at home.